台股 » 個股 » 台新藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台新藥

(6838)
可現股當沖
  • 股價
    29.00
  • 漲跌
    ▼1.45
  • 漲幅
    -4.76%
  • 成交量
    630
  • 產業
    上市 生技醫療類股
  • 20人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
台新藥 (6838)籌碼相關-富邦-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/2605/1005/2406/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0602/1602/2603/1003/2003/3004/0127.53032.53537.540May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

富邦-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/3100.001429.1329.00-14348-4.02%
2025/03/281530.60530.5530.45103392.95%
2025/03/27331.3500.0031.4033290.91%
2025/03/26132.1500.0032.0513260.31%
2025/03/25432.3000.0032.4043231.24%
2025/03/2000.00133.6033.25-1310-0.32%
2025/03/19134.0000.0034.4012890.35%
2025/03/130.232.2000.0031.800.22050.10%
2025/03/1200.002633.2133.10-26199-13.00%
2025/02/2700.00135.8035.50-1232-0.43%
2025/02/20337.35336.8036.4502270.00%
2025/02/18135.5000.0035.3012270.44%
2025/02/14136.7000.0036.4012260.44%
2025/02/1100.00334.3034.30-3227-1.32%
2025/02/1000.00534.2534.10-5228-2.19%
2025/01/1500.00333.9534.25-3297-1.01%
2025/01/13133.7000.0033.6013060.33%
2025/01/0900.00234.2034.30-2309-0.65%
2025/01/07135.2000.0035.1013220.31%
2025/01/06436.2900.0035.9043241.23%
2024/12/2600.00238.3538.60-2478-0.42%
2024/12/2400.00438.0538.00-4487-0.82%
2024/12/1000.001739.6339.80-17673-2.53%
2024/12/05640.63140.5040.4557830.64%
2024/12/04541.50141.4041.6047820.51%
2024/12/03342.22241.6541.7517860.13%
2024/12/02243.4500.0043.0027820.26%
2024/11/2900.00341.2342.50-3767-0.39%
2024/11/2800.00139.0038.65-1763-0.13%
2024/11/27138.70338.8538.70-2766-0.26%
2024/11/26139.3500.0039.3517700.13%
2024/11/25138.9500.0039.1017760.13%
2024/11/20139.70239.5539.25-1790-0.13%
2024/11/19139.6000.0039.6517960.13%
2024/11/18141.0000.0039.9018130.12%
2024/11/1500.00141.8041.70-1815-0.12%
2024/11/13142.8000.0042.6018340.12%
2024/11/07344.2000.0044.3539770.31%
2024/11/06545.20244.7544.3539800.31%
2024/11/0500.00246.9546.55-2978-0.20%
2024/11/0400.00445.9945.80-4972-0.41%
2024/11/0100.00645.0745.30-6966-0.62%
2024/10/30342.73342.6042.5009640.00%
2024/10/291143.01742.6942.6049680.41%
2024/10/28844.4300.0044.0589650.83%
2024/10/2500.003.145.1045.10-3.1975-0.32%
2024/10/2300.00144.0044.00-1977-0.10%
2024/10/22643.70443.5143.7529810.20%
2024/10/21144.1000.0044.3019830.10%
2024/10/1700.00444.8044.50-4993-0.40%
2024/10/16144.25244.6544.50-1997-0.10%
2024/10/15544.051244.1943.55-71,008-0.69%
2024/10/14845.1100.0044.7581,0010.80%
2024/10/11445.90645.5045.75-2999-0.20%
2024/10/09346.23946.2046.00-6991-0.61%
2024/10/081046.4000.0046.35109851.01%
2024/10/07348.72448.6548.25-1970-0.10%
2024/10/04349.58548.6748.65-2956-0.21%
2024/10/01650.34649.5749.2509350.00%
2024/09/30148.00747.8548.25-6880-0.68%
2024/09/2700.00943.6843.90-9838-1.07%
2024/09/26343.0000.0042.7538350.36%
2024/09/25243.4500.0043.1528350.24%
2024/09/24344.4300.0043.5038410.36%
2024/09/23144.2000.0044.4518300.12%
2024/09/1900.00145.8044.90-1817-0.12%
2024/09/18245.3500.0043.9528020.25%
2024/09/16745.2800.0044.6577980.88%
2024/09/131245.36145.9546.05117781.41%
2024/09/12142.10442.4141.90-3736-0.41%
2024/09/11643.22143.0042.5057230.69%
2024/09/10245.7315.145.0645.50-13.1694-1.89%
2024/09/09442.7900.0043.7546350.63%
2024/09/06239.73639.4739.80-4590-0.68%
2024/09/050.137.50537.4237.25-4.9581-0.84%
2024/09/0400.00837.3137.25-8579-1.38%
2024/09/030.138.90139.0038.55-0.9573-0.16%
2024/08/2900.00239.1039.50-2569-0.35%
2024/08/28138.90139.1038.9005640.00%
2024/08/27138.6000.0038.6515580.18%
2024/08/2600.00139.1538.90-1552-0.18%
2024/08/2000.00140.2539.20-1529-0.19%
2024/08/19438.93139.0039.0035100.59%
2024/08/1600.00139.7039.65-1498-0.20%
2024/08/15339.50139.7039.9024890.41%
2024/08/143.539.94239.8539.551.54770.31%
2024/08/13941.72841.9541.9514380.23%
台新藥授權夥伴向瑞士醫療藥品管理局 申請眼科新藥上市查驗登記Anue鉅亨-2025/02/14
〈焦點股〉台新藥眼科新藥出貨至美國展望正向 觸及漲停Anue鉅亨-2024/09/13
〈焦點股〉台新藥眼科新藥9月正式外銷至美國 漲逾半根停板Anue鉅亨-2024/09/06
台新藥 相關文章
台新藥 相關影音
 
 
62小時44